

Analysts downgraded SoundThinking, Moderna, Accelerant, Mobileye and Dow, revising their ratings and price targets.
You can purchase shares of Wave Life Sciences (NASDAQ:WVE) through any online brokerage.
Other companies in Wave Life Sciences’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Wave Life Sciences has a consensus price target of $22.08.
The stock price for Wave Life Sciences (NASDAQ: WVE) is $3.85 last updated October 29, 2026 at 10:26 AM EDT.
There are no upcoming dividends for Wave Life Sciences.
Wave Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Wave Life Sciences.
Wave Life Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM,...